...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Binding characterization of (3H)S-0139, an antagonist of the endothelin ET(A) receptor subtype.
【24h】

Binding characterization of (3H)S-0139, an antagonist of the endothelin ET(A) receptor subtype.

机译:(3H)S-0139,内皮素ET(A)受体亚型的拮抗剂的结合特征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

S-0139 (27-O-3-[2-(3-carboxy-acryloylamino)-5-hydroxyphenyl]-acryloylo xy myricerone, sodium salt) is a highly specific nonpeptide endothelin ET(A) receptor antagonist. The binding of [3H]S-0139 was compared to that of [125I]endothelin-1 to characterize the binding of the antagonist in porcine aortic smooth muscle membranes. Scatchard analysis revealed a single class of [3H]S-0139 binding sites with a Kd value of 0.61 +/- 0.10 nM and a Bmax of 0.72 +/- 0.16 pmol/mg protein. These sites were saturable and reversible. [125I]Endothelin-1 also showed binding with high affinity (Kd = 0.12 +/- 0.02 nM) to a homogeneous population of binding sites, whose Bmax (0.71 +/- 0.20 pmol/mg protein) was almost the same as that for [3H]S-0139. In both cases, the binding could be displaced by known endothelin receptor ligands and their IC50 values in each case showed a very close correlation (r = 0.986). The potency of seven endothelin receptor antagonists to displace [3H]S-0139 binding also correlated highly to the potency for inhibiting the endothelin-1-induced increase in cytosolic Ca2+ concentration (r = 0.949). Myriceric acid A showed a more potent functional activity than expected from its binding affinity, but this seemed to result from the different assay conditions, such as incubation time. Together, the results suggest that S-0139 labels only endothelin ET(A) receptor binding sites in porcine aortic smooth muscle.
机译:S-0139(27-O-3- [2-(3-羧基-丙烯酰基氨基)-5-羟苯基]-丙烯酰杨梅酮,钠盐)是一种高度特异性的非肽内皮素ET(A)受体拮抗剂。将[3H] S-0139的结合与[125I]内皮素-1的结合进行比较,以表征猪主动脉平滑肌膜中拮抗剂的结合。斯卡查德分析显示出一类[3H] S-0139结合位点,其Kd值为0.61 +/- 0.10 nM,Bmax为0.72 +/- 0.16 pmol / mg蛋白。这些位点是饱和的和可逆的。 [125I]内皮素-1还显示出与同质结合位点的高亲和力结合(Kd = 0.12 +/- 0.02 nM),其Bmax(0.71 +/- 0.20 pmol / mg蛋白质)几乎与[3H] S-0139。在这两种情况下,结合都可以被已知的内皮素受体配体所取代,并且每种情况下它们的IC50值都显示出非常紧密的相关性(r = 0.986)。七种内皮素受体拮抗剂取代[3H] S-0139结合的能力也与抑制内皮素1诱导的胞质Ca2 +浓度增加的能力高度相关(r = 0.949)。肉豆蔻酸A的功能活性比其结合亲和力预期的要强,但这似乎是由于不同的测定条件(例如孵育时间)导致的。在一起,结果表明S-0139只标记猪主动脉平滑肌中的内皮素ET(A)受体结合位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号